紫杉醇已经成为ＮＳＣＬＣ最重要的治疗药物 ,紫杉醇联合顺铂或卡铂已被证实是ＮＳＣＬＣ的标准方案 ,其有效率在 4 0 %左右[1] 。常规联合化疗方案中 ,紫杉醇每 3周应用一次。老年人晚期ＮＳＣＬＣ往往同时合并有器官功能低下 ,骨髓功能脆弱 ,难以承受强烈的联合化疗方案。常 Paclitaxel has become the most important treatment for NSCLC, and paclitaxel plus cisplatin or carboplatin has been shown to be the standard regimen for NSCLC with efficiencies of around 40% [1]. Paclitaxel is administered every 3 weeks in routine combination regimens. Elderly patients with advanced NSCLC often combined with organ dysfunction, fragile bone marrow function, unbearable strong combination chemotherapy. often